Italian cognitive robotics company Oversonic Robotics has added STMicroelectronics, Fondazione ENEA Tech Biomedical, and SpotInvest to its share capital as part of a capital and partnership expansion aimed at accelerating industrial, technological, and international development. The new investors join an existing shareholder base that includes Comat, Datalogic, and AVM SGR through the Cysero fund. Financial terms of the transaction were not disclosed. Oversonic is the developer of RoBee, described as the first cognitive humanoid robot certified to operate in factory environments.
STMicroelectronics, a global semiconductor supplier, is positioned to strengthen Oversonic’s industrial drive and technology roadmap, particularly in advanced manufacturing components relevant to humanoid platforms. Fabio Gualandris, president of quality, manufacturing and technology at STMicroelectronics, said the company sees automation, AI, and robotics as key enablers of the future of manufacturing. Fondazione ENEA Tech Biomedical supports Oversonic’s development of certified humanoids for healthcare applications, while SpotInvest, an investment vehicle attributable to entrepreneur Marco Setti, is oriented toward services and process automation opportunities in the food industry.
RoBee is already deployed in Italy and abroad and is positioned by Oversonic as an application infrastructure for factories and healthcare rather than a general-purpose humanoid. The company plans to use the expanded shareholder base to develop its technological platform further, evolve manufacturing and healthcare applications, strengthen its team, and expand industrial capacity. Chairman Fabio Puglia and CEO Paolo Denti said Italy will remain the company’s technological and industrial base, with Europe and the United States identified as the markets where the next stage of growth will be pursued. Oversonic has already established an operational presence in the United States and intends to deepen engagement with industrial partners, investors, and clients in the country.
The transaction reflects a broader pattern in which semiconductor suppliers and industrial component manufacturers are taking direct positions in humanoid robotics developers, similar to earlier moves by Nvidia, Foxconn, and other component and manufacturing players elsewhere. For humanoid startups, such partnerships provide access to supply chain expertise, component roadmaps, and industrial credibility that pure financial investors do not supply. Oversonic’s certification-focused positioning distinguishes it from developers pursuing broader consumer or research-oriented humanoid platforms. Whether that regulatory-first approach translates into durable commercial deployment across manufacturing, healthcare, and food industry customers will be the key test of the strategy as the company scales in Europe and the United States.
